These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 78152)

  • 21. Angiotensin blockade: its clinical significance.
    Streeten DH; Anderson GH; Dalakos TH
    Am J Med; 1976 May; 60(6):817-24. PubMed ID: 1020761
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
    Beyer J; Liebau G; Steiner B; Hayduk K
    Klin Wochenschr; 1978 Sep; 56(17):859-64. PubMed ID: 713415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension.
    Marks LS; Maxwell MH; Kaufman JJ
    Ann Intern Med; 1977 Aug; 87(2):176-82. PubMed ID: 889198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin blockade in postoperative paradoxical hypertension of coarctation of the aorta.
    Farrell BG; Parker FB; Poirier RA; Anderson G; Streeten DH; Blackman M
    Surg Forum; 1979; 30():189-90. PubMed ID: 395680
    [No Abstract]   [Full Text] [Related]  

  • 25. Correction of renal hypertension in the rat by prolonged infusion of angiotensin inhibitors.
    Riegger AJ; Lever AF; Millar JA; Morton JJ; Slack B
    Lancet; 1977 Dec 24-31; 2(8052-8053):1317-9. PubMed ID: 74729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of angiotensin antagonists in experimental and human renovascular hypertension.
    Maxwell MH
    Adv Nephrol Necker Hosp; 1979; 8():297-319. PubMed ID: 115245
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of saralasin in hypertensive patients on chronic hemodialysis.
    Lifschitz MD; Kirschenbaum MA; Rosenblatt SG; Gibney R
    Ann Intern Med; 1978 Jan; 88(1):23-7. PubMed ID: 619754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N; Madeddu P; Dessì-Fulgheri P; Meloni F; Palermo M; Fiori C; Rappelli A
    Boll Soc Ital Cardiol; 1980; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract]   [Full Text] [Related]  

  • 29. [The saralasin test in the diagnosis of hypertension (author's transl)].
    Bönner G; Helber A; Meurer KA; Hummerich W; Wambach G; Kaufmann W
    Dtsch Med Wochenschr; 1979 Mar; 104(12):432-7. PubMed ID: 436589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical experience with saralasin infusion in hypertensive patients.
    Tegtmeyer CJ; Latour EA; Vaughan ED; Ayers CR; Carey RM; Wellons HA
    Invest Radiol; 1977; 12(6):496-504. PubMed ID: 591250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sympathetic nerve hyperactivity in high-renin hypertension effects of saralasin infusion.
    DeQuattro V; Barbour BH; Campese V; Finck EJ; Miano L; Esler M
    Mayo Clin Proc; 1977 Jun; 52(6):369-73. PubMed ID: 865132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of saralasin on blood pressure, plasma renin and plasma noradrenaline in hypertensive patients].
    Bönner G; Lang R; Hummerich W; Helber A; Meurer KA; Wambach G; Kaufmann W
    Med Welt; 1980 Sep; 31(38):1362, 1363-5. PubMed ID: 7001167
    [No Abstract]   [Full Text] [Related]  

  • 33. Saralasin infusion in the recognition of renovascular hypertension.
    Wilson HM; Wilson JP; Slaton PE; Foster JH; Liddle GW; Hollifield JW
    Ann Intern Med; 1977 Jul; 87(1):36-42. PubMed ID: 879617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
    Van Hoogdalem P; Donker AJ; Leenen FH
    Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of renovascular hypertension with angiotensin II blockade.
    Baer L; Parra-Carrilo JZ; Radichevich I; Williams GS
    Ann Intern Med; 1977 Mar; 86(3):257-60. PubMed ID: 842983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects.
    Anderson GH; Streeten DH; Dalakos TG
    Circ Res; 1977 Mar; 40(3):243-50. PubMed ID: 837471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of saralasin on plasma renin activity and arginine-vasopressin in hypertensive man.
    Arlart IP; Rosenthal J; Wagner H; Franz HE
    Proc Eur Dial Transplant Assoc; 1978; 15():412-7. PubMed ID: 740674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The immediate pressor response to saralasin in man: a test of angiotensin II receptor vacancy.
    Wallace JM; Case DB; Laragh JH; Keim HJ; Drayer JI; Sealey JE
    Circ Res; 1979 Jan; 44(1):38-44. PubMed ID: 214254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease.
    Brod J; Bahlmann J; Cachovan M; Hubrich W; Pretschner D
    Nephron; 1980; 25(4):167-72. PubMed ID: 6990284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
    Case DB; Wallace JM; Keim HJ; Sealey JE; Laragh JH
    Am J Med; 1976 May; 60(6):825-36. PubMed ID: 1020762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.